ArticleBiomedical optics express2025
Advanced 3D retinal lesion segmentation using channel-spatial attention-guided multi-scale feature aggregation.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- AI-aided segmentation of four types of drusen in volumetric OCT.Biomedical optics express · 2025Article
- Advances in Technology and Applications of Optical Sensing and Imaging for Biomedicine: introduction to the feature issue.Biomedical optics express · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic macular edema (DME) and age-related macular degeneration (AMD) have emerged as leading causes of vision impairment worldwide; optical coherence tomography (OCT) has proven to be a crucial diagnostic tool for these diseases, for its rapid, non-invasive high-resolution imaging of retinal structures. Further accurate assessment of lesions in retinal OCT images plays a pivotal role in the early diagnosis of DME and AMD. However, current diagnosing of AMD and DME is restricted to utilizations of OCT two-dimensional images, for crucial three-dimensional (3D) lesion information inherent in OCT 3D images cannot be effectively extracted and utilized without appropriate methods. Here, we proposed an innovative deep-learning network characterized by fusing multi-scale feature extraction-aggregation and channel-spatial joint attention for high-accuracy 3D lesion segmentations of DME and AMD. Extensive experiment results demonstrated that our proposed method has commendable 3D segmentation performances and robust generalization capabilities, probably helping to understand DME and AMD diseases better and providing great convenience for clinical diagnosis and treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.